The Supreme Court on May 4 reinstated mail-order access to the widely used abortion drug mifepristone, a temporary decision that gives the justices more time to consider the issue.
The court intervened after the Food and Drug Administration was ordered on May 1 to revive a requirement that doctors prescribe the drug only after an in-person exam. It was the first time access to mifepristone had been significantly curtailed during years of litigation over the drug, which was first approved in 2000.
At the request of drugmakers, Justice Samuel Alito paused until May 11 the restrictive ruling by a lower court while the full court decides what the rules for mifepristone should be as Louisiana challenges expanded access.
“This ruling is not final − keep watching,” Nancy Northup, head of the Center for Reproductive Rights, said in a statement. “Getting abortion pills through telehealth has been a lifeline for women since Roe v. Wade was overturned. There is no reason people shouldn’t be able to get mifepristone at a pharmacy or through the mail.”
Health Glance
Three people have died in an outbreak of a dangerous respiratory virus on a cruise ship in the Atlantic Ocean, according to the World Health Organization.
The Centers for Medicare and Medicaid Services (CMS) unintentionally published Social Security data for at least 100 health providers, according to multiple outlets.
A former senior adviser at the National Institute of Allergy and Infectious Diseases is facing charges over an alleged scheme to hide federal records during the COVID-19 pandemic, the Justice Department said Tuesday.
A Pennsylvania court on Monday said that the state’s constitution guarantees a right to abortion while striking down a decades-long law banning the use of state Medicaid funds to cover abortion costs.
When Bug got home from school one winter afternoon in late 2024, his mother was on the couch, watching 30 Rock re-runs. Bug sat down next to her; he had an announcement to make.





























